For the year ending 2025-12-31, TCRT made $5K in revenue. -$4,176K in net income. Net profit margin of -83520.00%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 5 | 10 | ||
| Research and development | 1,363 | 362 | ||
| General and administrative | 2,867 | 4,460 | ||
| Total operating expenses | 4,230 | 4,822 | ||
| Loss from operations | -4,225 | -4,812 | ||
| Change in fair value of warrant liability | 31 | - | ||
| Other income , net | 80 | 133 | ||
| Other income (expense), net | 49 | 133 | ||
| Net loss | -4,176 | -4,679 | ||
| Basic EPS | -2.2 | -2.92 | ||
| Diluted EPS | -2.2 | -2.92 | ||
| Basic Average Shares | 1,948,357 | 1,601,252 | ||
| Diluted Average Shares | 1,948,357 | 1,601,252 | ||
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT)